RXI PHARMACEUTICALS CORP NEW's ticker is RXIIXXXX and the CUSIP is 74979C501. A total of 17 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 397,371 | $284,000 | 0.02% |
Hudson Bay Capital Management LP | 428,812 | $306,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 38 | $0 | 0.00% |
FNY Partners Fund LP | 179 | $0 | 0.00% |
Virtu KCG Holdings LLC | 27,689 | $20,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 1,096 | $1,000 | 0.00% |
IFP Advisors, Inc | 1 | $0 | 0.00% |
GOLDMAN SACHS GROUP INC | 57,159 | $41,000 | 0.00% |
Advisor Group, Inc. | 163 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 26,638 | $19,000 | 0.00% |